0001840574-21-000001.txt : 20210122 0001840574-21-000001.hdr.sgml : 20210122 20210122155851 ACCESSION NUMBER: 0001840574-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210122 DATE AS OF CHANGE: 20210122 EFFECTIVENESS DATE: 20210122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Verve Therapeutics, Inc. CENTRAL INDEX KEY: 0001840574 IRS NUMBER: 824800132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-387112 FILM NUMBER: 21545740 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (978) 501-3026 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001840574 Verve Therapeutics, Inc. 500 TECHNOLOGY SQUARE CAMBRIDGE MA MASSACHUSETTS 02139 (978) 501-3026 DELAWARE None None Corporation true 2018 Andrew Ashe 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Executive Officer Burt Adelman 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Director John Evans 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Director Sekar Kathiresan 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Anthony Philippakis 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Director Krishna Yeshwant 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Director Andrew Bellinger 500 Technology Square Cambridge MA MASSACHUSETTS 02139 Executive Officer Biotechnology Decline to Disclose 06b false 2021-01-14 false true false 0 93999993 93999993 0 false 22 0 0 0 false Verve Therapeutics, Inc. /s/ Andrew Ashe Andrew Ashe President and Chief Operating Officer 2021-01-22